📅 October 29 — 4:00 PM (CET)
Free registration:
The skin microbiome has emerged as one of the most dynamic areas of cosmetic R&D. The ecosystem of bacteria, fungi and microorganisms living on the skin surface is now recognized as a key factor in skin balance, tolerance and resilience and brands are racing to respond. Claims such as “microbiome-friendly”, “microbiome safe” and “respect microbiome” are among the fastest-growing in the industry, driven by three main axes: rebalancing through prebiotics and probiotics, probiotic-like actives, and antimicrobial approaches.
This momentum is reshaping how R&D teams think about formulation and, consequently, how they approach testing. Evaluating the impact of a cosmetic product on the skin microbiome requires specific methodologies that go far beyond traditional efficacy testing. Yet the landscape of available solutions remains complex and fragmented, making it difficult for formulators to identify the right approach for their claims and regulatory context.
To go further, Skinobs is hosting a live webinar on October 29, bringing together experts to explore the evaluation solutions available today:
- In vitro and ex vivo models for microbiome assessment
- Clinical protocols to measure the impact of cosmetic formulas on skin flora
- Sequencing and metagenomic approaches in cosmetic testing
- Criteria for selecting the right evaluation method for your formulation goals
Whether you are building your first microbiome testing strategy or looking to strengthen an existing one, this session will give you a clear and actionable overview of what exists and how to source it.
